A Stanford-led team has replaced toxic pre-transplant chemotherapy with a targeted antibody, allowing children with Fanconi anemia to receive stem cell transplants safely. The antibody, briquilimab, removes diseased stem cells without radiation, enabling nearly complete donor cell replacement. The approach also widens donor eligibility and could soon be applied to other bone marrow failure diseases.
from All Top News -- ScienceDaily https://ift.tt/J6UVk9d
Here different kind of articles available for people, simple and easy tips related to different topics.
No comments:
Post a Comment